Last €141.13 EUR
Change Today +1.02 / 0.73%
Volume 8.8K
AMG On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 1:02 PM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger M. Perlmutter M.D., Ph.D.

Former Consultant, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 2 different organizations across 8 different industries.

62--

Background*

Dr. Roger M. Perlmutter, M.D., Ph.D. has been the Executive Vice President and President of Merck Research Laboratories at Merck & Co. Inc. since April 15, 2013. Dr. Perlmutter serves as Science Partner at The Column Group LLC. Dr. Perlmutter was a Professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington in Seattle from January 1991 to January 1997. From 1981 to 1984, he was a Lecturer in the Division of Biology at the California ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Director
2000-2013
Former Director and Member of Corporate Governance & Nominating Committee
2012-2013
Former Director
2012-Present
Non-Executive Director
2012-N/A
Former Director and Member of Scientific Advisory Board

Education*

PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis
Unknown/Other Education 1973
Reed College

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMG:GR €141.13 EUR +1.02

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.